Premium Alternative Insight and Premium Journalism
The Latest
Dan Loeb’s multistrategy hedge fund cut the size of the short book in August.
The food delivery company set terms for its IPO and disclosed other details in a revised filing.
Why the volatile macro fund has gone from first to nearly worst in less than a year.
Ken Griffin’s multistrat fund continues to be one of the top performers in the category.
David Einhorn appears to have benefited, in part from the recent sharp boost of his short portfolio.
The Tiger Cub is poised to be the biggest winner when RayzeBio goes public.
The hedge fund giant is seeking capital for a new offering in its Alkali group of funds.
Sponsored
Amid a surprisingly strong economy, Morningstar is more bullish than consensus on falling inflation, GDP growth, and lower interest rates.
